Ticker
INKTCompany Name
MINK THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 69.29M | $ 7.92K | $ 0 | $ 0 | -0.01% |
3/31/2025 | $ 28.62M | $ 5.81M | $ 0 | $ 0 | -20.32% |
12/31/2024 | $ 32.68M | $ 5.82M | $ 5M | $ 0 | -33.11% |
9/30/2024 | $ 29.66M | $ 5.82M | $ 5M | $ 0 | -36.48% |
6/30/2024 | $ 33.55M | $ 5.82M | $ 5M | $ 0 | -32.24% |
3/31/2024 | $ 38.89M | $ -65.85K | $ 5M | $ 0 | -12.69% |
12/31/2023 | $ 30.88M | $ -407.17K | $ 0 | $ 0 | 1.32% |
9/30/2023 | $ 32.79M | $ -407.06K | $ 0 | $ 0 | 1.24% |
6/30/2023 | $ 66.26M | $ -409.52K | $ 0 | $ 0 | 0.62% |
3/31/2023 | $ 55.76M | $ -490.71K | $ 0 | $ 0 | 0.88% |
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for MINK THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 901 ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 11.11M ]) / Market Cap [ $ 0 ]
(=) Shareholder Yield [ 0% ]
Minimum
Sep 30, 2022
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.12% |